Why the study?
Necrosis in the tumor interior is associated with poor clinical prognosis and metastasis, but how the necrotic core promotes metastasis remains unclear.
Does Angptl7 loss reduce metastasis and central necrosis in breast cancer?
Does Angptl7 loss reduce metastasis and central necrosis in breast cancer?
Angptl7 is a tumor-specific factor that promotes vascular permeability and supports vascular remodeling in the perinecrotic zone, driving central necrosis formation and metastatic dissemination.
Tumor necrosis may promote breast cancer dissemination via Angptl7; hypothesis-generating and should not yet change practice.
Necrosis in the tumor interior is a common feature of aggressive cancers that is associated with poor clinical prognosis and the development of metastasis. How the necrotic core promotes metastasis remains unclear. Here, we report that emergence of necrosis inside the tumor is correlated temporally with increased tumor dissemination in a rat breast cancer model and in human breast cancer patients. By performing spatially focused transcriptional profiling, we identified angiopoietin-like 7 (Angptl7) as a tumor-specific factor localized to the perinecrotic zone. Functional studies showed that Angptl7 loss normalizes central necrosis, perinecrotic dilated vessels, metastasis, and reduces circulating tumor cell counts to nearly zero. Mechanistically, Angptl7 promotes vascular permeability and supports vascular remodeling in the perinecrotic zone. Taken together, these findings show that breast tumors actively produce factors controlling central necrosis formation and metastatic dissemination from the tumor core.
No takes yet. Share an insight, caveat, or question.
Yamamoto et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: